Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: A meta-analysis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 2, 2013, Pages 235-242

  Deshpande, Abhishek ^a   Pasupuleti, Vinay ^a   Thota, Priyaleela ^b   Pant, Chaitanya ^e   Mapara, Sulaiman ^c   Hassan, Sohaib ^b   Rolston, David D K ^f   Sferra, Thomas J ^d   Hernandez, Adrian V ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c St Vincent Charity Medical Center   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^f GEISINGER MEDICAL CENTER   (United States)

Author keywords

H2 receptor antagonist; Meta analysis; Proton pump inhibitor; Spontaneous bacterial peritonitis

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ARTICLE; ASCITES; BACTERIAL PERITONITIS; HUMAN; LIVER CIRRHOSIS; META ANALYSIS; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL;

EID: 84872793547     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12065     Document Type: Article

References (32)

1. Bustamante J, Rimola A, Ventura PJ etal. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J. Hepatol. 1999; 30: 890-895.
2. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin. Liver Dis. 2008; 28: 26-42.
3. Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut 2012; 61: 297-310.
4. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005; 41: 422-433.
5. Bauer TM, Steinbruckner B, Brinkmann FE etal. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am. J. Gastroenterol. 2001; 96: 2962-2967.
6. Bajaj JS, Zadvornova Y, Heuman DM etal. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am. J. Gastroenterol. 2009; 104: 1130-1134.
7. Chang CS, Chen GH, Lien HC, Yeh HZ. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 1998; 28: 1187-1190.
8. Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 1988; 8: 632-635.
9. Jump RL, Pultz MJ, Donskey CJ. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea? Antimicrob. Agents Chemother. 2007; 51: 2883-2887.
10. Deshpande A, Pant C, Pasupuleti V etal. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. Clin. Gastroenterol. Hepatol. 2012; 10: 225-233.
11. Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004; 292: 1955-1960.
12. Prod'hom G, Leuenberger P, Koerfer J etal. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial. Ann. Intern. Med. 1994; 120: 653-662.
13. Goel GA, Deshpande A, Lopez R, Hall GS, van Duin D, Carey WD. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression. Clin. Gastroenterol. Hepatol. 2011; 10: 422-427.
14. Stroup DF, Berlin JA, Morton SC etal. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
15. Wells GA, Shea B, O'Connell D etal. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. 2009. Cited December 2011. Available from URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
16. Hellstrom PM, Vitols S. The choice of proton pump inhibitor: does it matter? Basic Clin. Pharmacol. Toxicol. 2004; 94: 106-111.
17. Klok RM, Postma MJ, van Hout BA, Brouwers JR. Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use. Aliment. Pharmacol. Ther. 2003; 17: 1237-1245.
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986; 7: 177-188.
19. Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK. Risk of clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am. J. Gastroenterol. 2012; 107: 1011-1019.
20. Davies HT, Crombie IK, Tavakoli M. When can odds ratios mislead? BMJ 1998; 316: 989-991.
21. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002; 21: 1539-1558.
22. Deeks JJ, Higgins JPT, Altman DG. Analysing data and undertaking meta-analyses. In: Deeks JJ, Higgins JPT, Altman DG, eds. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. Chichester, UK: John Wiley & Sons, 2008; 243-296.
23. Loke YK, Price D, Herxheimer A. Adverse effects. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: John Wiley & Sons, 2008; 433-446.
24. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
25. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455-463.
26. Campbell MS, Obstein K, Reddy KR, Yang YX. Association between proton pump inhibitor use and spontaneous bacterial peritonitis. Dig. Dis. Sci. 2008; 53: 394-398.
27. Northup PG, Argo CL, Berg CL. Chronic proton pump inhibitor use is strongly associated with hepatorenal syndrome and spontaneous bacterial peritonitis in cirrhosis patients. Hepatology 2008; 48: 325A.
28. Bulsiewicz WJ, Scherer JR, Feinglass JM, Howden CW, Flamm SL. 63 Proton Pump Inhibitor (PPI) use is independently associated with spontaneous bacterial peritonitis (SBP) in cirrhotics with ascites. Gastroenterology 2009; 136: A-11.
29. Choi EJ, Lee HJ, Kim KO etal. Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites. Scand. J. Gastroenterol. 2011; 46: 616-620.
30. de Vos M, De Vroey B, Kidd F, Henrion J, Deltenre P. Do proton pump inhibitors or beta-blockers influence the occurrence of spontaneous bacterial peritonitis or the prognosis of cirrhotic patients with spontaneous bacterial peritonitis? 19th United European Gastroenterology Week; 22-26 October 2011, Stockholm, Sweden.
31. van Vlerken LG, Huisman EJ, van Hoek B, etal. Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability. Eur. J. Clin. Invest. 2012; 42: 760-767.
32. Trikudanathan G, Israel J, Cappa J, O'Sullivan DM. Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients-a systematic review and meta-analysis. Int. J. Clin. Pract. 2011; 65: 674-678.